Literature DB >> 3899350

A 3-dimensional tumor growth inhibition assay for testing monoclonal antibody cytotoxicity.

W Z Wei, R J Massey, G H Heppner.   

Abstract

A 3-dimensional tumor growth inhibition assay [18] has been adapted to test the cytotoxic activity of a panel of monoclonal antibodies directed to various antigenic determinants on the surface of mouse mammary tumor cells. Target cells can be prepared from either cultured cells or from pieces of fresh tumor. Antibody and complement are added when cells are growing actively and cell growth can be measured, non destructively, over a 7-10-day period. Effective diffusion of antibody through collagen gel and binding to target cells embedded in the gel is demonstrated by indirect immunofluorescent staining. The specificity of monoclonal antibody AMT 101 cytotoxicity for mouse mammary tumor cells is the same in trypan blue exclusion assays of single-cell suspensions as in collagen gel assays, with complete killing seen in the collagen gel assay only. The collagen gel assay allows the testing of repeated treatments in vitro, as well as combined treatment with multiple antibodies. It also allows cell-cell interaction and preserves all cell components in the tumor. The collagen gel assay has potential as a method of predicting the outcome of monoclonal antibody treatment of solid tumors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899350     DOI: 10.1007/bf00205680

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  23 in total

1.  Characterization of monoclonal antibodies to human melanoma-associated antigens.

Authors:  K Imai; A K Ng; S Ferrone
Journal:  J Natl Cancer Inst       Date:  1981-03       Impact factor: 13.506

2.  Topographical analysis of viral epitopes using monoclonal antibodies: mechanism of virus neutralization.

Authors:  R J Massey; G Schochetman
Journal:  Virology       Date:  1981-11       Impact factor: 3.616

3.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

4.  Interactions between tumor subpopulations affecting their sensitivity to the antineoplastic agents cyclophosphamide and methotrexate.

Authors:  B E Miller; F R Miller; G H Heppner
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

5.  Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG.

Authors:  G Galfrè; C Milstein; B Wright
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

6.  Ricin A-chain conjugated with monoclonal anti-L1210 antibody. In vitro and in vivo antitumor activity.

Authors:  K Kishida; Y Masuho; M Saito; T Hara; H Fuji
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

7.  Assessing tumor drug sensitivity by a new in vitro assay which preserves tumor heterogeneity and subpopulation interactions.

Authors:  B E Miller; F R Miller; G H Heppner
Journal:  J Cell Physiol Suppl       Date:  1984

8.  A spectrum of monoclonal antibodies reactive with human mammary tumor cells.

Authors:  D Colcher; P H Hand; M Nuti; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

9.  Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein.

Authors:  P Horan Hand; D Colcher; D Salomon; J Ridge; P Noguchi; J Schlom
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

10.  Characterization of cell surface antigens of human mammary epithelial cells with monoclonal antibodies prepared against human milk fat globule.

Authors:  R L Ceriani; J A Peterson; J Y Lee; R Moncada; E W Blank
Journal:  Somatic Cell Genet       Date:  1983-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.